Product Code: ETC9943536 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Emetogenic Drugs Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Emetogenic Drugs Market - Industry Life Cycle |
3.4 United Kingdom (UK) Emetogenic Drugs Market - Porter's Five Forces |
3.5 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume Share, By Class, 2021 & 2031F |
3.6 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume Share, By Types of Emesis, 2021 & 2031F |
3.7 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 United Kingdom (UK) Emetogenic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases requiring chemotherapy and radiation therapy |
4.2.2 Growing awareness among healthcare professionals about the effectiveness of emetogenic drugs in managing chemotherapy-induced nausea and vomiting |
4.2.3 Technological advancements leading to the development of more effective and targeted emetogenic drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of emetogenic drugs |
4.3.2 High cost associated with the development and production of emetogenic drugs |
4.3.3 Adverse side effects associated with certain emetogenic drugs, leading to concerns among patients and healthcare providers |
5 United Kingdom (UK) Emetogenic Drugs Market Trends |
6 United Kingdom (UK) Emetogenic Drugs Market, By Types |
6.1 United Kingdom (UK) Emetogenic Drugs Market, By Class |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Class, 2021- 2031F |
6.1.3 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Serotonin Receptor Antagonists (5-HT3 RAS), 2021- 2031F |
6.1.4 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Neurokinin-1 Receptor Antagonist (NK1 RAS), 2021- 2031F |
6.1.5 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By 5HT3 RA/NK1 RA Combination, 2021- 2031F |
6.1.6 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.7 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Olanzapine, 2021- 2031F |
6.1.8 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Emetogenic Drugs Market, By Types of Emesis |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Acute, 2021- 2031F |
6.2.3 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Delayed, 2021- 2031F |
6.2.4 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Anticipatory, 2021- 2031F |
6.2.5 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Breakthrough, 2021- 2031F |
6.2.6 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Refactory, 2021- 2031F |
6.2.7 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Chronic, 2021- 2031F |
6.3 United Kingdom (UK) Emetogenic Drugs Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Highly Emetogenic Chemotherapy, 2021- 2031F |
6.3.3 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Moderately Emetogenic Chemotherapy, 2021- 2031F |
6.3.4 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Low Emetogenic Chemotherapy, 2021- 2031F |
6.3.5 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Other, 2021- 2031F |
6.4 United Kingdom (UK) Emetogenic Drugs Market, By Drug Type |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Generic, 2021- 2031F |
6.5 United Kingdom (UK) Emetogenic Drugs Market, By End user |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United Kingdom (UK) Emetogenic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Emetogenic Drugs Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Emetogenic Drugs Market Export to Major Countries |
7.2 United Kingdom (UK) Emetogenic Drugs Market Imports from Major Countries |
8 United Kingdom (UK) Emetogenic Drugs Market Key Performance Indicators |
8.1 Number of clinical trials evaluating the efficacy and safety of new emetogenic drugs |
8.2 Adoption rate of emetogenic drugs in cancer treatment centers and hospitals |
8.3 Patient satisfaction scores related to the effectiveness of emetogenic drugs in managing nausea and vomiting |
9 United Kingdom (UK) Emetogenic Drugs Market - Opportunity Assessment |
9.1 United Kingdom (UK) Emetogenic Drugs Market Opportunity Assessment, By Class, 2021 & 2031F |
9.2 United Kingdom (UK) Emetogenic Drugs Market Opportunity Assessment, By Types of Emesis, 2021 & 2031F |
9.3 United Kingdom (UK) Emetogenic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United Kingdom (UK) Emetogenic Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.5 United Kingdom (UK) Emetogenic Drugs Market Opportunity Assessment, By End user, 2021 & 2031F |
10 United Kingdom (UK) Emetogenic Drugs Market - Competitive Landscape |
10.1 United Kingdom (UK) Emetogenic Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Emetogenic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |